D-Pharm Ltd

D-Pharm is a biopharmaceutical company focused on the discovery and development of innovative lipid-based drugs for the treatment of central nervous system disorders, cancer and autoimmune diseases.

D-Pharm's pipeline includes two products in Phase II for epilepsy and acute stroke, and three in pre-clinical development for Parkinson’s and cancer.

Activity:

- Clinical Trials
- Licensing & Business Development
- Research & Development

Product / Technology type(s) covered:

- Bio
- Drug delivery
- NCE (new chemical entities)
- Pharmaceuticals / Therapeutics
- Technology

Therapeutic targets:

- Alzheimer's Disease
- Cancer
- Central nervous system
- Neurology
- Pain
- Stroke

Markets Covered

a. HeadQuarter: Israel

b. Continent(s) active: North America , Europe , Far East

c. Countries active: US, Japan, Europe

Corporate data:

Number of Employees: 110

Turnover:

Amount:	Year:	Currency:
-	2002	US Dollar

Year founded: 1993